Northeast Pharmaceutical Group (000597) Net Profit Attributable to Parent Saw Year-on-year Increase of 385%; Being Better than Expectation --- Overweight

  • Contributor:TX Investment Consulting
  • Date:Apr 27, 2009
  • Pages:5pages
  • Price:$80.00
  • File Type: Adobe Acrobat Reader®
Download Free Adobe Acrobat Reader®

Research Reports Premium Services

-Get the full report for $80.00

-The financial products you have ordered will be sent to   you within 24 hours via e-mail.

Excerpts:

The company released its Q1 2009 report, according to which it realized business turnover of Rmb1396mn (+25.10% yoy), net profit attributable to parent of Rmb157mn (+433.77% yoy), and EPS of Rmb0.471.

 

We hereby maintain its earning forecast in 2009-2010E EPS to be Rmb1.70 and Rmb2.05, representing dynamic P/E ratio at 12x and 10x based on closing price of Rmb20.49 on April 24, 2009. “Overweight” rating remains intact.


SSL